Hormone Replacement Therapy Market Size to Hit USD 53.9 Bn by 2030

According to Precedence Research, the global hormone replacement therapy market size is predicted to hit around USD 53.9 billion by 2030 and growing at a CAGR of 6.4% from 2022 to 2030.

Ottawa, July 07, 2022 (GLOBE NEWSWIRE) -- The global hormone replacement therapy market size was valued at USD 31.4 billion in 2021. The prime drivers of hormone replacement therapy are extended interest from regenerative solutions, for instance, against developing and conceptive cycle supporting therapy like menopausal hormonereplacement. Rising revenue in other helpful areas, for instance, growth hormone therapy and thyroid hormone therapy due to almost safe profile, capability, and cost suitability of these prescriptions should influence market improvement.

Get the Free Sample Copy of Report@ https://www.precedenceresearch.com/sample/1852

Additionally, new definitions, for instance, transdermal drugs, gels and creams that recommendation benefits, for instance, straightforwardness of prescription association and impact at region should fabricate the advancement of hormone replacement therapy market during the gauge time span.

Key Takeaways:

  • In 2021, the North America region was estimated at USD 10.87 billion
  • Asia Pacific region is growing at a CAGR of 12.7% over the forecast period 2022 to 2030
  • By product, U.S. hormone replacement therapy market was estimated at USD 8.5 billion in 2021
  • The menopause indication segment accounted market share of 48% in 2021
  • The growth hormone deficiency segment has garnered revenue share of 20% in 2021
  • Human growth hormone replacement therapy segment is growing at a CAGR of 12.3% over the forecast period
  • In 2021, the parental segment has garnered revenue share of 41%

Regional Snapshot

North America managed the general market for hormone replacement therapy to the extent that pay share in 2021. Works out like progression the medicine movement structures, improvement of new subtleties, and rising objective people inside North America should stay aware of its solidarity over the gauge period. The NIH communicates that piece of the postmenopausal women have used HRT something like once.

Asia Pacific, on the other hand, should notice the speediest improvement over the check period from 2022 to 2030. Extending care levels and rising point of convergence of clinical benefits providers on the annihilation of hormonal needs should help the advancement of the market inside the region.

Ask here for more customization study@ https://www.precedenceresearch.com/customization/1852

Scope of the Report

Report AttributesDetails
Market Size in 2021USD 31.4 Billion
Revenue Forecast by 2030USD 53.9 Billion
CAGR6.4% from 2022 to 2030
Largest MarketNorth America
Fastest Growing RegionAsia Pacific
Base Year2021
Forecast Year2022 to 2030
Key PlayersNovo Nordisk A/S, Pfizer Inc., Endo International Plc, Allergen Plc, Janssen NV, Novartis AG, Bayer AG, Merck KGaA, Mithra Pharmaceuticals, Teva Pharmaceuticals, Mylan N.V, and Others

Report Highlights

  • Estrogen replacement therapy is used in women during post-menopause or hysterectomy and helps them with staying aware of the hormonal balance. Estrogen-based things have been pondered to make the greatest number of arrangements likewise making it the greatest piece.
  • The parenteral piece governed the general market to the extent that pay share in 2020. The oral course of association is generally enjoyed for testosterone drugs. The other piece is complete of things like vaginal creams, embeds, vaginal rings, and vaginal tablets.
  • In the sort of disease part, menopause should be the speediest creating area over the measure period from 2022 to 2030. According to the estimations given by the American Congress of Obstetricians and Gynecologists, around 6,000 women show up at menopause consistently.
  • In the sort of sickness part, menopause should be the fastest creating area over the measure period from 2022 to 2030. According to the estimations given by the American Congress of Obstetricians and Gynecologists, around 6,000 women show up at menopause consistently.

Market Dynamics


The essential issue that contributes toward the improvement of the overall hormone replacement therapy market recall climb for regularity of menopausal issue and extension in care about post-menopausal issues among women. Besides, new farewells of hormone replacement therapy should prominently contribute toward the hormone replacement therapy market improvement. Regardless, negative effects of hormone replacement therapy and huge cost of therapy are supposed to hamper the market advancement during the check time span.


As indicated by the U.S Women's Health Initiative, the utilization of blend hormone supplanting therapy accompanies the gamble of advancement of a few tumors including ovarian disease and uterus malignant growths. This viewpoint is supposed to keep the development in reception of hormone replacement therapy in the impending years. Other hormone replacement therapy related problems, for example, stroke, heart issues and blood clumps are additionally expected to adversely affect the development of the hormone replacement therapy market.


The new item improvement as an essential methodology is embraced by the main organizations to upscale their market presence among buyers. These methodologies have brought about the development of hormone replacement therapy market.


The affordability has consistently stayed a significant challenge for any drug medication or plan. Besides, lacking medical services repayments have brought about people deciding on less expensive medications with hazy medication adequacy. This provoked fabricates of hormone replacement therapy medications to deliver nonexclusive variants of the details in a bid to overcome any issues between buying force of individuals and hormone replacement therapy drug evaluating.

Related Reports

Get Our Latest Press Releases@ https://www.precedenceresearch.com/press-releases

Recent Developments

  • In August 2020, Bayer AG declared the securing of KanDy Therapeutics Inc., which helps with the development of Bayer's ladies' medication pipeline by adding KanDy's menopause medication to its portfolio.
  • In December 2020, the US FDA supported Thyquidity (levothyroxine) oral arrangement, of VistaPharm, for replacement therapy of essential (thyroidal), auxiliary (pituitary), and tertiary (hypothalamic) innate or obtained hypothyroidism, alongside an extra endorsement as an assistant to medical procedure and radioiodine therapy in the administration of thyrotropin-subordinate very much separated thyroid disease.
  • In August 2020, the US FDA supported Sogroya (somapacitan), a human development hormone (HGH) therapy for grown-up patients with development hormone lack, which is shown to be required once seven days by infusion under the skin. Accordingly, the high pattern of item endorsements is likewise expected to drive the concentrated on market in the district.
  • In October 2018, the US FDA endorsed bioidentical estradiol and progesterone containers (Bijuva) of Therapeutics MD as hormonetherapy for menopausal ladies experiencing moderate to extreme vasomotor side effects.

Market Segmentation

By Product

  • Oestrogen Hormone Replacement Therapy
  • Human Growth Hormone Replacement Therapy
  • Thyroid Hormone Replacement Therapy
  • Testosterone Hormone Replacement Therapy

By Route of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Others

By Indication

  • Menopause
  • Hypothyroidism
  • Male Hypogonadism
  • Growth Hormone Deficiency
  • Others

By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies & Stores
  • Online Pharmacies

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Immediate Delivery Available | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1852

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com  | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

For Latest Update Follow Us: